• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 0.00
( 0.00%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Poojawestern Metaliks Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
540727
INE973X01012
14.2595149
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
18.86
16.64
EPS(TTM)
Face Value()
Div & Yield %
0.87
10
0
 

Beryl Drugs standalone net profit rises 273.33% in the March 2026 quarter
May 29,2026
Net profit of Beryl Drugs rose 273.33% to Rs 0.56 crore in the quarter ended March 2026 as against Rs 0.15 crore during the previous quarter ended March 2025. Sales rose 29.22% to Rs 5.13 crore in the quarter ended March 2026 as against Rs 3.97 crore during the previous quarter ended March 2025.

For the full year,net profit declined 27.59% to Rs 0.42 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales declined 11.02% to Rs 18.82 crore in the year ended March 2026 as against Rs 21.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales5.133.97 29 18.8221.15 -11
OPM %25.9312.59 -12.8112.53 -
PBDT1.260.42 200 2.072.12 -2
PBT0.860.10 760 0.580.87 -33
NP0.560.15 273 0.420.58 -28